INSTITUT DE RECHERCHES INTERNATIONALES SERVIER
- Country
- France
- Type
- Beneficiary
- Website
- www.servier.com
- Grants received
- 12
Funding record
- 12 grants on record
- €310,500 awarded in total
- 2015–2021 span of the record
Grants recorded here are the ones our sources publish, and the total is the sum of those. It is not a statement of this organisation's total funding.
Programmes
10 further grants are on record without a programme named by the source, or under a programme outside the largest shown here.
Frequent partners
Organisations this one has been funded alongside on two or more projects. A single shared consortium is not counted: the largest here has 195 members, and being on one list together is not a collaboration.
- JANSSEN PHARMACEUTICA NV
- NOVARTIS PHARMA AG
- BAYER AKTIENGESELLSCHAFT
- GLAXOSMITHKLINE RESEARCH & DEVELOPMENT LIMITED
- SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT
- ASTRAZENECA AB
- ELI LILLY AND COMPANY LTD
- THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD
Calls from this organisation
No published calls from this organisation.
Grants received
- Accelerating Development and Improving Access to CAR and TCR-engineered T cell therapy
- Prioritisation and Risk Evaluation of Medicines in the EnviRonment
- EU Patient- cEntric clinicAl tRial pLatform
- NEw Clinical Endpoints in primary Sjögren’s Syndrome: an Interventional Trial based on stratifYing patients
- Patients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medicines for better health outcomes.
- IN-Silico trials for treatment of acute Ischemic STroke
- Enhacing TRANslational SAFEty Assessment through Integrative Knowledge Management
- Big Data 4 Better Hearts - Sofia ref.: 116074
- Big Data for Better Outcomes, Policy Innovation and Healthcare System Transformation - Sofia ref.: 116055
- Translational quantitative systems toxicology to improve the understanding of the safety of medicines - Sofia: 116030
- Targeting epigenetic REPROGRamming of innate immune cells in Atherosclerosis Management and other chronic inflammatory diseases
- Accelerated Development of Appropriate Patient Therapies: a Sustainable, Multi-stakeholder Approach from Research to Treatment-outcomes - Sofia ref.: 115890
Data source
© European Union, 2026. Source: CORDIS. Reused under Commission Decision 2011/833/EU — CC BY 4.0.
Retrieved from the source on .
Personal data of natural persons has been dissociated by quiescence.eu.
This service is not affiliated with, sponsored or endorsed by the data publishers.